Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed?
| Autor: | Manly JJ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Irving Medical Center, New York, New York., Deters KD; Department of Integrative Biology and Physiology, University of California, Los Angeles. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JAMA [JAMA] 2023 Aug 08; Vol. 330 (6), pp. 510-511. |
| DOI: | 10.1001/jama.2023.11704 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|